A year af­ter em­bark­ing on a new HQ and man­u­fac­tur­ing site, Ab­Cellera starts sec­ond phase of its build­out

A year ago, Cana­di­an an­ti­body biotech Ab­Cellera broke ground on the first phase of its head­quar­ters ex­pan­sion in Van­cou­ver, along with a new man­u­fac­tur­ing site …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.